IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Mayo Clinicmonoclonal_antibodyPhase 2/3Active
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 52/ 100
- Competitive Position
- 95/ 100
Competitive context
17 Active assets in the Diffuse Large B-Cell Lymphoma Activated B-Cell Type cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide National Cancer Institute (NCI) | Phase 3 | BB |
VINCRISTINE SULFATE National Cancer Institute (NCI) | Phase 2/3 | BB |
PREDNISONE TABLETS National Cancer Institute (NCI) | Phase 2/3 | BB |
Inno-206 National Cancer Institute (NCI) | Phase 2/3 | BB |
Evomela National Cancer Institute (NCI) | Phase 3 | B |
View all 20 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →